Korro Bio: Promising Early Stage RNA Editing Company
Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
Novel class of zwitterionic phospholipids enhances mRNA delivery
A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...
Scientists demonstrate pre-clinical proof of concept for next-gen DNA delivery technology
Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
MyChesCo on MSN2d
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates
Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, ...
Technology Networks2d
The Future of RNA Therapeutics, From Design to Delivery
Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.
Arbutus Biopharma Corporation: Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 202 ...
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.
Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for its Epigenetic Reprogramming Therapies
ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms ...
DNA-loaded lipid nanoparticles are poised to bring gene therapy to common chronic diseases
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...
AI-powered Cancer Vaccine In The Works
RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
Pharmabiz5d
US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14
US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...